ライフサイエンスコーパス: enteropathy

1 rates intestinal radiation injury (radiation enteropathy).

2 due to severe noninflammatory protein-losing enteropathy.

3 cluding HAART-related adverse events and HIV enteropathy.

4 c disease is a diet-induced, T cell-mediated enteropathy.

5 spected to have an associated protein-losing enteropathy.

6 and histologic evidence of gluten-sensitive enteropathy.

7 ly includes a minority of patients with mild enteropathy.

8 itis, motility, malabsorption, and radiation enteropathy.

9 y drug users develop subclinical small bowel enteropathy.

10 ations of nonsteroidal antiinflammatory drug enteropathy.

11 the key factor in staphylococcal enterotoxin enteropathy.

12 to be correlated with the degree (extent) of enteropathy.

13 ntrol mice or those exhibiting NSAID-induced enteropathy.

14 c event, and 1 (2%) developed protein-losing enteropathy.

15 ular NSAID users may be prone to small bowel enteropathy.

16 or hypoalbuminemia are useful clues to NSAID enteropathy.

17 ovesicular rash and is often associated with enteropathy.

18 t the disease arises secondary to hereditary enteropathy.

19 esents an in vitro model of gluten-sensitive enteropathy.

20 d Bob activation is a plausible cause of HIV enteropathy.

21 l small intestine in a murine model of NSAID enteropathy.

22 contributes substantially to the associated enteropathy.

23 rotein is feasible and ameliorates radiation enteropathy.

24 role for drug adduct formation in diclofenac enteropathy.

25 some infection was primarily associated with enteropathy.

26 ths and no patients developed protein losing enteropathy.

27 hunting, thromboembolism, and protein-losing enteropathy.

28 been additionally diagnosed with celiac-like enteropathy.

29 CeD) is a common gluten-sensitive autoimmune enteropathy.

30 as revealed as an AIE-75-positive autoimmune enteropathy.

31 with HIV status, and also with environmental enteropathy.

32 of, and, ideally, assess interventions for, enteropathy.

33 viously carried out studies on environmental enteropathy.

34 ong-term effects and avoid chronic allograft enteropathy.

35 rization of the pathogenesis of HIV-mediated enteropathy.

36 ymphocytes that may also play a role in some enteropathies.

37 syndrome (SBS) (59%), PNDD (14%), congenital enteropathies (10%), chronic intestinal pseudo-obstructi

38 (32%), thrombosis (12%), and protein-losing enteropathy (8%).

39 Acquired enteropathy affecting both gut structure and function li

40 nclusion disease (MVID), a lethal hereditary enteropathy affecting neonates.

41 unction, such as environmental (or tropical) enteropathy, affects zinc absorption, losses, and homeos

42 nfortunately these molecules cause a gastric enteropathy after chronic dosing in rats.

43 a case of EATL complicating adult autoimmune enteropathy (AIE).

44 is factor (TNF) in graft-versus-host disease enteropathy, an adenoviral vector encoding a TNF inhibit

45 cations for the pathogenesis of TNF-mediated enteropathies and chronic inflammatory diseases of the i

46 ions, and 1 patient each with protein-losing enteropathy and ascites.

47 microbial component, including environmental enteropathy and chronic colitis-associated colorectal ca

48 c has the potential to resolve environmental enteropathy and clear bacterial pathogens, we aimed to a

49 eric viral infections may contribute to AIDS enteropathy and disease progression.

50 ome, which may contribute to AIDS-associated enteropathy and disease progression.

51 r human X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome (IPEX; MIM 30493

52 developments in the area of acute radiation enteropathy and examine the current state of knowledge r

53 d allergic enterocolitis with protein-losing enteropathy and had low birth weight.

54 s to be the predominant isoform in radiation enteropathy and may be more important in the mechanisms

55 IV/pigtailed macaque model of HIV to examine enteropathy and microbial translocation.

56 of Gla KO mice provides a model for study of enteropathy and neuropathy in Fabry disease.

57 profound congenital sensorineural deafness, enteropathy and renal tubular dysfunction.

58 despite reducing biomarkers of environmental enteropathy and the prevalence of pathogenic intestinal

59 Enteric infections, enteropathy and undernutrition in early childhood are pr

60 This could be a mechanism of SIV-associated enteropathy and viral pathogenesis.

61 s herpetiformis (DH) have a gluten-sensitive enteropathy and while on gluten-containing diets have el

62 iated with the development of protein-losing enteropathy and with decreased survival.

63 by immune dysregulation, polyendocrinopathy, enteropathy and X-linked inheritance (MIM 304930).

64 correlated with all parameters of radiation enteropathy and, after adjusting for radiation dose and

65 sive means of detecting and monitoring NSAID enteropathy (and possibly other gastrointestinal mucosal

66 entified 5 children with polyendocrinopathy, enteropathy, and dermatitis reminiscent of IPEX syndrome

67 munity, polyclonal lymphocytic infiltration, enteropathy, and lymphoid malignancy.

68 t presented with lymphedema, protein loosing enteropathy, and sclerosing cholangitis and was diagnose

69 Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX) is one of a

70 d by immune-dysfunction, polyendocrinopathy, enteropathy, and X-linked inheritance.

71 se immune dysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome (IPEX).

72 ave immunodysregulation, polyendocrinopathy, enteropathy, and X-linked syndrome.

73 alabsorption caused by chronic environmental enteropathy are associated with growth faltering seen in

74 inal translocation of microbial products and enteropathy as well as alterations in gut bacterial comm

75 trast enhanced ultrasound (CEUS) findings in enteropathy associated T-cell lymphoma (EATL) complicati

76 Enteropathy associated T-cell lymphoma (EATL) is a rare

77 ory coeliac disease (RCD) type I and II, and enteropathy associated T-cell lymphoma (EATL).

78 he intestinal microbiota might contribute to enteropathy associated with use of nonsteroidal anti-inf

79 Enteropathy-associated T-cell lymphoma (EATL) is a compl

80 Enteropathy-associated T-cell lymphoma (EATL) is a rare

81 Enteropathy-associated T-cell lymphoma (EATL) is a rare

82 Enteropathy-associated T-cell lymphoma (EATL) is a rare

83 The refractory state itself and enteropathy-associated T-cell lymphoma (EATL) were the m

84 tions of celiac disease that may progress to enteropathy-associated T-cell lymphoma (EATL).

85 ac disease) appears to be a manifestation of enteropathy-associated T-cell lymphoma in most cases.

86 tion-to-treat analysis in 252 nodal PTCL and enteropathy-associated T-cell lymphoma patients (excludi

87 negative anaplastic large cell lymphoma, and enteropathy-associated T-cell lymphoma were enrolled.

88 Enteropathy-associated T-cell lymphoma, an often fatal c

89 ties, with the exception of 2 of 10 cases of enteropathy-associated T-cell lymphoma.

90 patient with the characteristic phenotype of enteropathy-associated T-cell lymphoma.

91 me clonally expanded in refractory sprue and enteropathy-associated T-cell lymphoma.

92 fections and their associated complications, enteropathy, autoimmunity, and lymphoproliferative disor

93 Enteropathy, autoimmunity, granulomas, and splenomegaly

94 data supporting the notion of protein-losing enteropathy being a consequence of severe iron deficienc

95 the nutritional components of environmental enteropathy by analyzing the specific metabolic and gut-

96 ly infection the viruses themselves cause an enteropathy by heretofore undetermined mechanisms.

97 n reduced faecal biomarkers of environmental enteropathy (calprotectin, myeloperoxidase, alpha1-antit

98 t interactions, anorexia, and protein-losing enteropathy can all contribute to the protein-calorie ma

99 and excluded, a unique entity known as AIDS enteropathy can be diagnosed.

100 results are encouraging, and protein-losing enteropathy can be expected to resolve.

101 Although AIDS enteropathy can pose a diagnostic challenge so too does

102 Coeliac disease (CD), an enteropathy caused by cereal gluten ingestion, is charac

103 The gluten-sensitive enteropathy celiac disease is tightly associated with th

104 (TG2) are a hallmark of the gluten-sensitive enteropathy celiac disease.

105 et of autoantibodies in the gluten-sensitive enteropathy celiac disease.

106 Lymphocytic enteropathy (celiac disease and lymphocytic duodenosis)

107 mmunodeficiency-associated and environmental enteropathies, celiac disease, inflammatory bowel diseas

108 In addition to the characteristic enteropathy, celiac disease is associated with various e

109 disease is a gluten-induced immune-mediated enteropathy characterized by a specific genetic genotype

110 Coeliac disease is a common enteropathy characterized by an increased mortality main

111 eliac disease is a gluten-induced autoimmune enteropathy characterized by the presence of tissue tran

112 l lymphangiectasia (PIL) is a protein-losing enteropathy characterized by tortuous and dilated lymph

113 me, rejection particularly chronic allograft enteropathy continues to be a major barrier to long-term

114 a for prevention and treatment of radiation, enteropathy could become a reality and would be of subst

115 Congenital tufting enteropathy (CTE) is a rare autosomal recessive diarrhea

116 Congenital tufting enteropathy (CTE) is a severe autosomal recessive human

117 etes (T1D) often experience gastrointestinal enteropathy (DE) of unclear etiology.

118 ly have intestinal symptoms, termed diabetic enteropathy (DE), though its etiology is unknown.

119 nd histopathological injury during radiation enteropathy development.

120 e from a patient with attaching-and-effacing enteropathy displayed the localized adherence attaching-

121 intestine likely plays a role in intestinal enteropathy during HIV infection.

122 Environmental enteropathy (EE) impairs the gut's absorptive capacity a

123 Environmental enteropathy (EE) is an asymptomatic abnormality of small

124 re collectively referred to as environmental enteropathy (EE).

125 is model, we found that Salmonella-inflicted enteropathy elicits parallel blooms of the pathogen and

126 genital syndrome characterized by autoimmune enteropathy, endocrinopathy, dermatitis, and other autoi

127 a useful drug in the treatment of autoimmune enteropathy, even in patients who have not responded to

128 tinal permeability with diarrhea, called HIV enteropathy, even without enteric opportunistic infectio

129 and allergic manifestations including severe enteropathy, food allergies, atopic dermatitis, hyper-Ig

130 ctocolitis (FPIAP), and food protein-induced enteropathy (FPE).

131 pecimens from patients with gluten-sensitive enteropathy (GSE) (obtained during gluten challenge) as

132 Classically, enteropathy has been identified histopathologically.

133 tinal pathogens and associated environmental enteropathy has been proposed to explain this problem.

134 ept of extraintestinal presentations without enteropathy has only recently become accepted.

135 s of heart failure death were protein-losing enteropathy (HR, 7.1; P=0.0043), single morphologically

136 oody diarrhea, malabsorption, protein-losing enteropathy, hypoalbuminemia, and failure to thrive.

137 idosis presenting with severe protein-losing enteropathy, hypoalbuminemia, and proximal myopathy who

138 ficant problem worldwide, with environmental enteropathy implicated as a contributing factor.

139 n gastrointestinal tract, eventually causing enteropathies in predisposed individuals.

140 el syndrome in 12 patients (27%), intestinal enteropathy in 20 patients (44%), and motility disorder

141 NO may therefore be an important mediator of enteropathy in both Th1- and Th2-inducing conditions.

142 Enteropathy in HIV infection is not eliminated with comb

143 a role in the pathogenesis of GI disease and enteropathy in HIV-infected people.

144 ibute to the development of NSAID-associated enteropathy in human beings.

145 wasting syndrome characterized by severe SIV enteropathy in the absence of opportunistic infections.

146 TNF inhibition decreases the severity of enteropathy in the DBA/2 --> B6D2F1 murine model of colo

147 marker and supports a role for environmental enteropathy in the pathogenesis of growth shortfall.

148 a) model of diarrhea, causing characteristic enteropathies, including inflammation, necrosis, and col

149 rated structural manifestations of radiation enteropathy, including radiation injury score (6.5 +/- 0

150 iac disease (CD), a T helper 1 cell-mediated enteropathy induced by gluten.

151 l administration of anti-CD3 ameliorated the enteropathy induced by intraperitoneal injection of the

152 present controlled study, the effect of the enteropathy induced by this organism on the retinal vasc

153 Enteropathy is a frequent complication of diclofenac and

154 Nonsteroidal antiinflammatory drug enteropathy is a stepwise process involving direct mucos

155 NSAID enteropathy is a stepwise process involving direct mucos

156 Tropical enteropathy is an asymptomatic villous atrophy of the sm

157 Autoimmune enteropathy is characterized by chronic secretory diarrh

158 cosal IL-10 in SIV/HIV infection in inducing enteropathy is not well understood.

159 ng the pathophysiology and diagnosis of this enteropathy is the difficulty of obtaining information a

160 The molecular basis of protein-losing enteropathy is unknown.

161 HIV-associated enteropathy is well-documented in chronic HIV-1 infectio

162 Childhood gut dysfunction (enteropathy) is common in resource-poor environments.

163 Celiac disease (CD), or gluten-sensitive enteropathy, is a common multifactorial disorder resulti

164 Celiac Sprue, or gluten-sensitive enteropathy, is an inheritable human disease of the smal

165 Coeliac disease, or gluten-sensitive enteropathy, is only one aspect of a range of possible m

166 sociated autoimmune disease gluten-sensitive enteropathy, leaving little room for a differential envi

167 oimmunity and alopecia, a condition we named enteropathy-lymphocytopenia-alopecia.

168 This enteropathy may appear at any age and is characterized b

169 us, suggesting that EE with superimposed HIV enteropathy may be a distinct pathophysiological conditi

170 HIV enteropathy may result from direct effects of HIV on gas

171 Myosin-5B malfunction causes the congenital enteropathy microvillus inclusion disease, underlining i

172 endothelial cells and in vivo in a radiation enteropathy mouse model confirm that genes involved in N

173 s trigger celiac disease (CD), an autoimmune enteropathy occurring in genetically susceptible persons

174 ole in the pathogenesis of acute and chronic enteropathies of dogs, including idiopathic inflammatory

175 wed characteristics typical of proliferative enteropathies of other animals, i.e., intracellular colo

176 completed the study, 119 (73%) had tropical enteropathy on enrollment (L:M > 0.10).

177 Patients with enteropathy or intestinal mucosal inflammation (associat

178 Children with enteropathy or intestinal mucosal inflammation are at gr

179 findings (eg, heart failure, protein-losing enteropathy, or new arrhythmias), and somatic growth.

180 In mice with enteropathy, oral anti-CD3 reduced levels of inflammator

181 HEV seropositivity was associated with worse enteropathy (P = .05 and P = .005, respectively).

182 significantly shorter than patients without enteropathy (P = 0.007).

183 Heart Association III/IV, or protein-losing enteropathy/plastic bronchitis) 20 years after Fontan wa

184 chronic effusions (n = 4) or protein-losing enteropathy (PLE) (n = 5) after lateral tunnel-type Font

185 kedown was required in 3% and protein-losing enteropathy (PLE) developed in 6%.

186 Patients with protein-losing enteropathy (PLE) fail to maintain intestinal epithelial

187 Patients with protein-losing enteropathy (PLE) following the Fontan operation have a

188 Protein-losing enteropathy (PLE) is a rare syndrome of gastrointestinal

189 Protein-losing enteropathy (PLE), characterized by loss of proteins in

190 Protein-losing enteropathy (PLE), the loss of plasma proteins through t

191 fficiency, and development of protein-losing enteropathy (PLE).

192 Protein-losing enteropathy (present in 34 patients) resolved in all who

193 ac disease (CD) is an increasingly diagnosed enteropathy (prevalence, 1:200-1:300) that is induced by

194 Both experimental enteropathies produced mucosal damage, although injury w

195 crolimus (FK506) in patients with autoimmune enteropathy refractory to steroids and cyclosporine.

196 The histology of tropical enteropathy resembles that seen in small-bowel bacterial

197 year-old boy presented with a protein-losing enteropathy secondary to a hypertrophic gastropathy.

198 howed that in those patients with ataxia and enteropathy, separate antibody populations react with th

199 ercise capacity, arrhythmias, protein-losing enteropathy, somatic growth retardation, neo-aortic valv

200 ogenesis of tissue-specific inflammation and enteropathies such as CD.

201 Celiac disease (CD) is a gluten-sensitive enteropathy that develops in genetically susceptible ind

202 medications in the world, yet they induce an enteropathy that is associated with high morbidity and m

203 , angiopathic thrombosis, and protein-losing enteropathy (the CHAPLE syndrome) is caused by abnormal

204 sal gene expression contribute to intestinal enteropathy, the role of small noncoding RNAs, specifica

205 entricular failure, cyanosis, protein-losing enteropathy, thromboembolism, and dysrhythmias often lea

206 g-term follow-up of patients with autoimmune enteropathy treated with tacrolimus is currently availab

207 Celiac disease is an enteropathy triggered by dietary gluten found in wheat,

208 Celiac disease is an immune-mediated enteropathy triggered by gliadin, a component of the gra

209 Celiac disease (CD) is an immune-mediated enteropathy triggered by gluten in genetically susceptib

210 Celiac disease (CD) is an immune-mediated enteropathy triggered by the ingestion of gluten-contain

211 Celiac disease (CD) is an autoimmune enteropathy triggered in susceptible individuals by the

212 treatment of 31 patients with a diagnosis of enteropathy-type intestinal T-cell lymphoma treated at t

213 The risk is highest for enteropathy-type T-cell lymphoma (ETL) and B-cell lympho

214 s, showed that in addition to protein-losing enteropathy, ventricular indexed end-diastolic volume >1

215 Radiation enteropathy was also associated with sustained shifts in

216 In the ileum and colon, enteropathy was associated with increased caspase-3 stai

217 A previously undescribed enterococcal enteropathy was associated with preretinal neovasculariz

218 ith clinical parameters only, protein-losing enteropathy was associated with transplantation-free sur

219 Gluten-sensitive enteropathy was found in 24%.

220 yanosis was present in 7, and protein-losing enteropathy was present in 4.

221 ium and the causative agent of proliferative enteropathy, was developed using an Original Space Bag i

222 In contrast the patient with an autoimmune enteropathy, was HLA-DQ9/DQ6-positive, also arguing agai

223 To identify candidate etiologies for AIDS enteropathy, we used next-generation sequencing to defin

224 ss, and physiological changes resembling HIV enteropathy were previously found in the HT-29 intestina

225 Environmental enteropathy, which is linked to undernutrition and chron

226 ncy virus (SIV) infection is associated with enteropathy, which likely contributes to AIDS progressio

227 Three patients with diagnosed autoimmune enteropathy who continued to have intractable diarrhea d

228 DDs) are a collection of rare, heterogeneous enteropathies with early onset and often severe outcomes

229 nclusion disease (MVID) is a rare intestinal enteropathy with an onset within a few days to months af

230 iarrhea caused by early-onset protein-losing enteropathy with primary intestinal lymphangiectasia, ed

231 The clinical effects of gluten-sensitive enteropathy with villous atrophy limited to the duodenal

232 e and immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX) patients.

233 nt of immunodysregulation polyendocrinopathy enteropathy X-linked-like syndrome.

234 of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders.

235 Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare, fatal a

236 th immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, associated with a

237 ith immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, the human disease

238 de immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, which is caused b

239 he immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome.

240 se immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX).

241 Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX; OMIM 304930) syndrome is a

242 he immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) and found them to

243 of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) with or without FO

244 ome (immune dysfunction, polyendocrinopathy, enteropathy, X-linked syndrome) in humans.

245 EX (immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) mutations.

246 the immune dysregulation polyendocrinopathy, enteropathy, X-linked syndrome, or X-linked autoimmunity

247 nd immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

248 me; immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome; Crohn's disease; and fam

249 X (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) patients.

250 X (immune dysregulation, polyendocrinopathy, enteropathy, X-linked) patients.

251 X (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), caused by a lack of regulatory T

252 d an immune dysregulation-polyendocrinopathy-enteropathy-X-linked (IPEX)-like phenotype for STAT1 mut